Definition
Antiepileptic drugs (AEDs) are used to treat epilepsy, i.e., the repeated occurrence of unprovoked epileptic seizures. They are also used in other conditions, e.g., bipolar disorder, neuropathic pain, or migraine. None of the available AEDs does cure epilepsy. Instead, they suppress epileptic discharges in the brain, thereby reducing seizure frequency. For this reason, they are sometimes called anticonvulsants or antiseizure drugs. Nevertheless, the official ATC code for these drugs as designated by the WHO is “N03A Antiepileptics.”
The prevalence of epilepsy is about 0.7% worldwide, with equal distribution between sexes. Thus, epilepsy is among the four most common neurologic disorders. The incidence vs. age curve is U-shaped, meaning that the incidence of epilepsy is highest at both extremes of age. At young age, epilepsy is mostly due to connatal brain disease, hypoxia at birth,...
References
Ambrosio AF, Soares-Da-Silva P, Carvalho CM, Carvalho AP (2002) Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res 27(1–2):121–130. https://doi.org/10.1023/a:1014814924965
Ben-Menachem E (2011) Mechanism of action of vigabatrin: correcting misperceptions. Acta Neurol Scand Suppl 192:5–15. https://doi.org/10.1111/j.1600-0404.2011.01596.x
Bertone NI, Groisman AI, Mazzone GL, Cano R, Tabares L, Uchitel OD (2017) Carbonic anhydrase inhibitor acetazolamide shifts synaptic vesicle recycling to a fast mode at the mouse neuromuscular junction. Synapse 71(12). https://doi.org/10.1002/syn.22009
Ceolin L, Bortolotto ZA, Bannister N, Collingridge GL, Lodge D, Volianskis A (2012) A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochem Int 61(4):517–522. https://doi.org/10.1016/j.neuint.2012.02.035
Chuang SH, Reddy DS (2019) Isobolographic analysis of antiseizure activity of the GABA-A receptor-modulating synthetic neurosteroids brexanolone and ganaxolone with tiagabine and midazolam. J Pharmacol Exp Ther. https://doi.org/10.1124/jpet.119.261735
Citraro R, Leo A, De Caro C, Nesci V, Gallo Cantafio ME, Amodio N, Mattace Raso G, Lama A, Russo R, Calignano A, Tallarico M, Russo E, De Sarro G (2020) Effects of histone Deacetylase inhibitors on the development of epilepsy and psychiatric comorbidity in WAG/Rij rats. Mol Neurobiol 57(1):408–421. https://doi.org/10.1007/s12035-019-01712-8
Cortes-Altamirano JL, Olmos-Hernandez A, Bonilla-Jaime H, Bandala C, Gonzalez-Maciel A, Alfaro-Rodriguez A (2016) Levetiracetam as an antiepileptic, neuroprotective, and hyperalgesic drug. Neurol India 64(6):1266–1275. https://doi.org/10.4103/0028-3886.193801
Delorenzo RJ, Sun DA (2002) Phenytoin and other hydantoins. Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (eds) Antiepileptic drugs, 5th edn. Lippincott Williams & Wilkins, Philadelphia
Errington AC, Coyne L, Stohr T, Selve N, Lees G (2006) Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 50(8):1016–1029. https://doi.org/10.1016/j.neuropharm.2006.02.002
Gaston TE, Friedman D (2017) Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy Behav 70 (Pt B):313–318. https://doi.org/10.1016/j.yebeh.2016.11.016
Greenfield LJ Jr (2013) Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure 22(8):589–600. https://doi.org/10.1016/j.seizure.2013.04.015
Hamidi S, Avoli M (2015) Carbonic anhydrase inhibition by acetazolamide reduces in vitro epileptiform synchronization. Neuropharmacology 95:377–387. https://doi.org/10.1016/j.neuropharm.2015.04.015
Hedera P, Cibulcik F, Davis TL (2013) Pharmacotherapy of essential tremor. J Cent Nerv Syst Dis 5:43–55. https://doi.org/10.4137/JCNSD.S6561
Kay HY, Greene DL, Kang S, Kosenko A, Hoshi N (2015) M-current preservation contributes to anticonvulsant effects of valproic acid. J Clin Invest 125(10):3904–3914. https://doi.org/10.1172/JCI79727
Klein P, Diaz A, Gasalla T, Whitesides J (2018) A review of the pharmacology and clinical efficacy of brivaracetam. Clin Pharmacol 10:1–22. https://doi.org/10.2147/CPAA.S114072
Kukkar A, Bali A, Singh N, Jaggi AS (2013) Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res 36(3):237–251. https://doi.org/10.1007/s12272-013-0057-y
Madeja M, Wolf C, Speckmann EJ (2001) Reduction of voltage-operated sodium currents by the anticonvulsant drug sulthiame. Brain Res 900(1):88–94. https://doi.org/10.1016/s0006-8993(01)02262-4
McKeage K, Keam SJ (2009) Pregabalin: in the treatment of postherpetic neuralgia. Drugs Aging 26(10):883–892. https://doi.org/10.2165/11203750-000000000-00000
Motaghinejad M, Motevalian M, Fatima S, Beiranvand T, Mozaffari S (2017) Topiramate via NMDA, AMPA/kainate, GABAA and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats. J Neural Transm (Vienna) 124(11):1369–1387. https://doi.org/10.1007/s00702-017-1771-2
Nickels KC, Wirrell EC (2017) Stiripentol in the management of epilepsy. CNS Drugs 31(5):405–416. https://doi.org/10.1007/s40263-017-0432-1
Plumlee KH (2004) Pharmaceuticals. In: Plumlee KH (ed) Clinical veterinary toxicology. Mosby, St. Louis, pp 282–336
Ramadan E, Basselin M, Rao JS, Chang L, Chen M, Ma K, Rapoport SI (2012) Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder. Int J Neuropsychopharmacol 15(7):931–943. https://doi.org/10.1017/S1461145711001003
Reimers A, Ljung H (2019) An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy. Expert Opin Pharmacother 20(8):909–915. https://doi.org/10.1080/14656566.2019.1595584
Reiss WG, Oles KS (1996) Acetazolamide in the treatment of seizures. Ann Pharmacother 30(5):514–519. https://doi.org/10.1177/106002809603000515
Riss J, Cloyd J, Gates J, Collins S (2008) Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 118(2):69–86. https://doi.org/10.1111/j.1600-0404.2008.01004.x
Rudzinski LA, Velez-Ruiz NJ, Gedzelman ER, Mauricio EA, Shih JJ, Karakis I (2016) New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel. J Investig Med 64(6):1087–1101. https://doi.org/10.1136/jim-2016-000151
Striano P, McMurray R, Santamarina E, Falip M (2018) Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice. Epileptic Disord 20(1):13–29. https://doi.org/10.1684/epd.2017.0950
Vogl C, Mochida S, Wolff C, Whalley BJ, Stephens GJ (2012) The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway. Mol Pharmacol 82(2):199–208. https://doi.org/10.1124/mol.111.076687
White HS, Smith MD, Wilcox KS (2007) Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol 81:85–110. https://doi.org/10.1016/S0074-7742(06)81006-8
Wilson SM, Khanna R (2015) Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide. Mol Neurobiol 51(2):599–609. https://doi.org/10.1007/s12035-014-8775-9
Wood M, Daniels V, Provins L, Wolff C, Kaminski RM, Gillard M (2020) Pharmacological profile of the novel antiepileptic drug candidate Padsevonil: interactions with synaptic vesicle 2 proteins and the GABAA receptor. J Pharmacol Exp Ther 372(1):1–10. https://doi.org/10.1124/jpet.119.261149
Zhou JJ, Li DP, Chen SR, Luo Y, Pan HL (2018) The alpha2delta-1-NMDA receptor coupling is essential for corticostriatal long-term potentiation and is involved in learning and memory. J Biol Chem 293(50):19354–19364. https://doi.org/10.1074/jbc.RA118.003977
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag Berlin Heidelberg New York
About this entry
Cite this entry
Reimers, A. (2020). Antiepileptic Drugs. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_150-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-21573-6_150-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21573-6
Online ISBN: 978-3-030-21573-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences